retatrutide liver Since January 2026, there have been six cases of acute toxicity associated with unapproved peptide products labelled in Australia. These toxic effects may be linked to a contaminant in the Victoria warns after six liver

Description

Kardashian was initially surprised by the public's demand for this product

An oral version of these drugswhich are known as glucagon-like peptide 1 (GLP-1) receptor agonistscould be more accessible and would come without the inconvenience, pain or medical waste of shots

doi: 10.1172/JCI186652 47 GuarnottaVBiancoMJVigneriEPantoFLo SassoBCiaccioMet al

[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Ocular adverse events with semaglutide: a systematic review and meta-analysis

Choi_ Nikolai stock.adobe.com News Weight loss and diabetes medication GLP-1 agonists may interfere with cancer imaging, new study finds The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research presented at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM'25) has revealed. GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023